Athens, Greece.


Working together to improve patient care is our credo. This year at the 13th European Multidisciplinary Congress on Urological Cancers (EMUC21), we will place more emphasis on the importance of multi-sectoral approach when offering the best care to patients.

The EMUC21 scientific programme will comprise of contemporary relevant developments in the prevention, diagnosis and management of genito-urinary (GU) cancers. Its scope will include the new WHO classification of GU cancers, modern imaging in prostate cancer, integrating systemic therapy in non-muscle-invasive bladder cancer, updates on major trials, recent molecular developments in the field, and more.

Registration for the EMUC21 Congress is now open.

Consult the Scientific Programme here:

A technical exhibition will be held jointly with the congress. The exhibition will be open to all technical equipment manufacturers, pharmaceutical companies and scientific publishers. This is a unique opportunity for your company to enhance your corporate visibility among the global urological community, as well as to promote your products and activities to the congress delegates.  The exhibition space will be assigned on a first-come, first-served basis. If your company is interested in having a booth at the congress please contact:

EMUC sales department
T: +31 (0)26 389 1751